Bank of New York Mellon Corp
BankPosition in RXRX — Recursion Pharmaceuticals, Inc.
CIK 1390777
NEW YORK, NY
Position in RXRX
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$4,490,274
-$137,898 QoQ
Shares Held
1,462,631
+29.3% QoQ
Ownership
0.276%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
20 quarters on record
Voting authority
Sole 86%
Shared 0%
None 14%
Common Shares in RXRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Bank of New York Mellon Corp holds $4,203,063,863 across 270 Biotechnology names. RXRX ranks #93 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,586,427 | $708,403,098 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
765,411 | $591,387,145 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,679,371 | $317,485,079 | |
| 4 | INSM |
INSMED Inc
|
1,262,749 | $206,484,708 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
491,200 | $162,523,337 | |
| 6 | INCY |
Incyte Corp
|
989,709 | $93,151,403 | |
| 7 | TECH |
BIO-TECHNE Corp
|
1,759,119 | $91,931,549 | |
| 8 | MRNA |
Moderna, Inc.
|
1,691,205 | $85,913,207 |
All Filings in RXRX
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,490,274 | 1,462,631 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $4,628,172 | 1,131,583 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $6,683,923 | 1,369,657 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $5,470,884 | 1,081,203 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $4,566,452 | 863,224 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $5,750,296 | 850,636 | Shares | Defined | 2025-02-04 | |
| 2024-09-30 | $6,103,115 | 926,118 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $7,956,028 | 1,060,804 | Shares | Defined | 2024-07-25 | |
| 2024-03-31 | $8,791,643 | 881,810 | Shares | Other | 2024-04-25 | |
| 2023-12-31 | $8,216,089 | 833,275 | Shares | Defined | 2024-01-29 | |
| 2023-09-30 | $4,850,174 | 634,010 | Shares | Defined | 2023-10-24 | |
| 2023-06-30 | $4,457,295 | 596,693 | Shares | Defined | 2023-08-03 | |
| 2023-03-31 | $3,529,475 | 529,157 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $3,896,996 | 505,447 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $5,361,931 | 503,941 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $3,250,732 | 399,353 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $2,675,691 | 373,700 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $6,293,664 | 367,406 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $2,393,660 | 104,027 | Shares | Defined | 2021-11-18 | |
| 2021-06-30 | $2,678,881 | 73,394 | Shares | Defined | 2021-08-11 | |
| No filing history on record for this holder in this stock. | ||||||